1. Introduction

Risk classification of biological experiments is a fundamental component of biotechnology law, biosafety regulation, public health governance and environmental protection. It refers to the systematic process of identifying, evaluating and categorising biological research activities according to the potential risks they may create for human health, animals, plants, ecosystems and society.

Biological experiments may involve genetically modified organisms (GMOs), pathogenic microorganisms, recombinant DNA, gene editing, synthetic biology, human biological samples, stem cells, infectious agents and experimental vaccines. These activities can produce significant scientific benefits, but they may also create risks such as accidental infection, environmental contamination, genetic modification of unintended organisms, laboratory exposure and uncontrolled biological release.

Risk classification determines the level of regulatory supervision, laboratory containment, institutional approval, researcher qualifications, monitoring, reporting and emergency preparedness required before an experiment can proceed.

The central legal principle is proportionality: the greater the potential biological harm, the stronger the safeguards and regulatory oversight should be.

2. Meaning and Nature of Risk Classification

Risk classification is a regulatory mechanism through which biological experiments are divided into categories based on their potential hazards and the likelihood and consequences of harm.

It generally considers:

Nature of the biological agent: Whether the experiment involves harmless microorganisms, potentially pathogenic organisms or highly dangerous infectious agents.

Human health risks: Whether exposure could cause infection, disease, disability or death.

Environmental risks: Whether an organism could escape containment, reproduce or affect biodiversity.

Genetic risks: Whether genetic modification could produce unintended biological characteristics.

Exposure pathways: Whether harm could occur through inhalation, direct contact, ingestion or environmental release.

Containment requirements: Whether ordinary laboratory precautions or specialised high-containment facilities are necessary.

Uncertainty: Whether scientific knowledge is sufficient to predict the experiment's consequences.

Risk classification is not simply a determination that an organism is dangerous or harmless. It is an assessment of the particular activity, the organism involved, the experimental purpose and the surrounding conditions.

3. Major Categories of Biological Experiment Risk

京都大学・京都府立医科大学近接のP2/BSL-2対応シェア型ウェットラボ 「Share Lab EVER SHIMOGAMO」2026年度：入居募集を開始 | 人と情報の交流掲示板 | LINK-J

Oficjalny portal miasta Gdańska

MED’s Biology of the Lung Funded through Its 50th—Yes, 50th—Year | BU Today | Boston University

11

A. Low-risk biological experiments

These experiments generally involve biological materials that present minimal risks to researchers and the environment.

Examples include:

Research involving non-pathogenic microorganisms.

Basic molecular biology experiments.

Non-infectious biological samples.

Routine laboratory studies using established safety procedures.

Legal requirements may include institutional registration, appropriate laboratory practices, staff training and waste-management procedures.

However, a low-risk classification does not automatically eliminate regulatory responsibilities.

B. Moderate-risk biological experiments

These experiments involve biological agents or activities that may cause disease or other harm under particular circumstances.

Examples include:

Research involving organisms associated with treatable infections.

Certain recombinant DNA experiments.

Research involving potentially infectious human samples.

Experiments requiring enhanced laboratory precautions.

Such activities may require institutional biosafety committee review, documented risk assessments, restricted laboratory access and appropriate protective equipment.

C. High-risk biological experiments

High-risk experiments involve biological agents or procedures that may create serious consequences for human health, animals or the environment.

Examples include:

Research involving serious infectious diseases.

Certain experiments involving genetically modified pathogenic organisms.

Research involving biological materials requiring specialised containment.

Activities presenting substantial risks of accidental exposure.

These experiments may require specialised facilities, additional institutional approvals, regulatory supervision, emergency-response procedures and continuous monitoring.

D. Very-high-risk biological experiments

Some biological activities may involve exceptionally serious consequences, particularly where exposure could result in severe disease, widespread transmission or substantial environmental damage.

Such activities may require the highest available containment standards and specialised regulatory authorisation.

Their legality depends on the particular biological agent, research purpose, applicable legislation and whether the proposed activity can be adequately controlled.

Important distinction: Biosafety Levels 1–4 (BSL-1 to BSL-4) describe laboratory containment practices and facility requirements. They are related to, but not identical with, risk groups assigned to biological agents. The experiment itself must also be assessed.

4. Risk Groups and Biosafety Levels

Biological risk classification commonly uses four risk groups.

These categories are useful for identifying biological hazards, but they do not automatically determine the containment level required for every experiment.

For example, the same biological agent may require different precautions depending on whether researchers are conducting routine diagnostic work, handling concentrated material or performing a procedure with greater exposure potential.

The World Health Organization (WHO), in its Laboratory Biosafety Manual, Fourth Edition (2020), advocates a case-by-case, evidence-based risk assessment rather than mechanically assigning laboratory safety levels according to an organism's risk group.

World Health Organization+2

5. Legal Framework Governing Biological Experiment Classification in India

India regulates biological experiments through environmental, biotechnology, public health and institutional safety legislation.

A. Environment (Protection) Act, 1986

The Environment (Protection) Act, 1986 provides the principal statutory foundation for regulating environmentally hazardous biological activities.

Important provisions include:

Section 3: Empowers the Central Government to take measures to protect and improve environmental quality.

Section 5: Authorises directions to regulate or prohibit activities that may threaten environmental protection.

Section 6: Provides authority to make rules concerning environmental protection.

Section 8: Requires compliance with prescribed safeguards when handling hazardous substances.

These provisions provide the statutory basis for controlling biological experiments that may affect public health or the environment.

B. Rules, 1989 concerning genetically engineered organisms

The Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Micro-organisms/Genetically Engineered Organisms or Cells, 1989 are particularly important.

Rule 5 – Classification of microorganisms

The Rules classify microorganisms and genetically engineered organisms under two principal categories:

Animal pathogens.

Plant pests.

The classification follows the schedules to the Rules.

Rule 6 – Classification of biological agents

The Rules identify categories including:

Bacterial agents.

Fungal agents.

Parasitic agents.

Viral, rickettsial and chlamydial agents.

Special-category agents.

Rule 7 – Approval and prohibition

The Rules regulate activities involving specified hazardous microorganisms and genetically engineered organisms, including import, export, transport, manufacture, processing, use and sale.

The Genetic Engineering Appraisal Committee (GEAC) plays an important role in the approval framework, alongside other competent regulatory bodies and institutional committees.

Indian Kanoon

C. Institutional Biosafety Committees

Institutional Biosafety Committees (IBSCs) are important in assessing proposed biological research.

Their responsibilities include:

Examining research proposals.

Reviewing biological hazards.

Assessing laboratory facilities.

Recommending containment and safety measures.

Monitoring compliance.

Reporting incidents where required.

The institutional assessment is important because regulatory responsibility does not end when a research project receives initial approval.

D. Other relevant legislation

6. International Legal and Regulatory Framework

A. Cartagena Protocol on Biosafety, 2000

The Cartagena Protocol on Biosafety is an important international instrument dealing with the safe handling, transfer and use of living modified organisms.

Its key objectives include:

Protection of biodiversity.

Assessment of potential environmental risks.

Safe transboundary movement of living modified organisms.

Information exchange between countries.

Appropriate risk-management measures.

Article 15 addresses risk assessment, while Article 16 concerns risk management.

The Protocol is especially relevant where biological experiments involve living modified organisms that may subsequently be transferred or released across national borders.

B. WHO Laboratory Biosafety Manual

The WHO manual establishes internationally recognised technical guidance for biological risk assessment.

It emphasises that risk classification should consider:

The biological agent.

The experimental procedure.

The possible routes of exposure.

Laboratory infrastructure.

Researcher competence.

Potential consequences of accidental release.

Its central contribution is the movement from a rigid classification approach towards a dynamic, evidence-based assessment.

C. Australian Gene Technology Act 2000

Australia provides another useful comparative model.

Under the Gene Technology Act 2000, the Gene Technology Regulator assesses proposed dealings with genetically modified organisms.

Section 50 requires preparation of a Risk Assessment and Risk Management Plan (RARMP) before issuing the relevant licence, subject to the statutory framework and applicable exceptions.

This system connects the classification of biological activities with licensing, public safety and environmental protection.

Federal Register of Legislation+1

7. Risk Assessment Procedure Before Approval of Biological Experiments

Risk classification must be supported by a documented assessment process.

The principal legal and regulatory stages are:

Stage 1: Identification of biological hazards

The institution identifies the biological materials and potential hazards involved.

Stage 2: Evaluation of exposure and consequences

The assessment considers the possibility of exposure and the seriousness of potential harm.

Stage 3: Determination of initial risk

The proposed activity is assigned an appropriate risk category based on the available evidence.

Stage 4: Selection of risk controls

The institution determines which safeguards, containment measures, training and supervision are necessary.

Stage 5: Evaluation of residual risk

The institution considers whether the remaining risk is acceptable after safeguards are applied.

Stage 6: Approval and monitoring

The appropriate authority or institutional committee determines whether the experiment may proceed and under what conditions.

Stage 7: Periodic reassessment

The assessment must be revisited when the experiment changes, new scientific evidence emerges or an incident occurs.

The WHO framework specifically stresses that risk assessment is a continuing process rather than a one-time approval exercise.

World Health Organization+1

8. Detailed Case Laws Relating to Biological Risk Classification

An important legal distinction is necessary: Indian courts have not established a comprehensive judicial classification system for every type of biological experiment. However, several decisions establish principles governing scientific uncertainty, hazardous activities, GMO safety and environmental risk assessment.

Case 1. Vellore Citizens' Welfare Forum v. Union of India (1996)

Supreme Court of India

Citation: (1996) 5 SCC 647; AIR 1996 SC 2715.

Facts:

The case concerned environmental pollution caused by tanneries in Tamil Nadu. Industrial effluents contaminated agricultural land and water resources, creating serious environmental and public health concerns.

Legal issues:

Whether potentially harmful activities could continue without adequate environmental safeguards.

Whether scientific uncertainty justified postponing preventive measures.

Who should bear responsibility for demonstrating environmental safety.

Judgment:

The Supreme Court recognised the precautionary principle and polluter-pays principle as essential components of sustainable development and Indian environmental law.

The Court explained that where serious or irreversible environmental harm is threatened, scientific uncertainty cannot justify postponing preventive measures.

It also placed the burden on the developer or industrial actor to demonstrate that the activity is environmentally benign.

Relevance to biological experiments:

This decision supports precautionary risk classification in biotechnology.

Where a proposed biological experiment may cause serious environmental damage, regulatory authorities should not automatically approve it merely because conclusive evidence of harm is unavailable.

A researcher proposing a potentially hazardous environmental activity may be required to provide adequate evidence of safety.

Indian Kanoon+1

Case 2. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999)

Supreme Court of India

Citation: (1999) 2 SCC 718.

Facts:

The dispute involved the proposed establishment of a hazardous industry near drinking-water reservoirs.

The controversy concerned the adequacy of environmental assessment and the scientific uncertainties surrounding the potential consequences.

Legal issues:

How should authorities assess activities involving scientific uncertainty?

What role should scientific experts play in regulatory decision-making?

Who should bear the burden of demonstrating safety?

Judgment:

The Supreme Court emphasised the importance of scientific expertise in environmental decision-making.

It recognised that environmental decisions frequently involve uncertainty and that regulatory institutions must take a precautionary approach.

Relevance to biological experiments:

The case provides an important foundation for independent scientific evaluation of biotechnology proposals.

An institution should not classify a biological experiment as low-risk merely because the applicant claims that the experimental material is safe.

Risk assessment should be supported by credible scientific evidence, expert evaluation and transparent reasoning.

Indian Kanoon+1

Case 3. A.P. Pollution Control Board v. Prof. M.V. Nayudu (2000)

Citation: (2001) 2 SCC 62.

Facts and legal issues:

The Supreme Court further examined scientific uncertainty and the institutional capacity of environmental authorities to make technically complex decisions.

Judgment:

The Court discussed the relationship between scientific knowledge, environmental regulation and the precautionary principle.

It recognised the importance of expert bodies in resolving complex environmental questions.

Relevance:

The judgment supports the use of multidisciplinary scientific committees when classifying biological experiments.

For example, a proposal involving genetically modified organisms may require expertise in genetics, microbiology, ecology, public health and environmental law.

Indian Kanoon+1

Case 4. Aruna Rodrigues v. Union of India (2017)

Supreme Court of India

Citation: W.P. (C) No. 260 of 2005, order dated 10 March 2017.

Facts:

The litigation concerned biosafety concerns arising from genetically modified organisms and the regulatory process for their environmental release.

The petitioners raised concerns regarding scientific examination, environmental effects and the adequacy of regulatory safeguards.

Legal issues:

Whether GMO approvals require adequate biosafety assessment.

Whether environmental release should be preceded by scientific scrutiny.

Whether regulatory decision-making must account for potential ecological harm.

Judicial significance:

The proceedings highlighted the importance of rigorous biosafety assessment before allowing potentially hazardous GMOs to enter the environment.

Relevance:

The case is directly relevant to biological risk classification because it demonstrates why the assessment of genetic modification must extend beyond the immediate laboratory experiment to potential environmental consequences.

Sci API+1

Case 5. Aruna Rodrigues v. Union of India (2024)

Supreme Court of India

Citation: 2024 INSC 310; judgment dated 18 April 2024.

Facts:

The Supreme Court considered challenges concerning the environmental release of genetically modified mustard and the adequacy of the regulatory approval process.

Legal issues:

Whether adequate scientific assessment had been undertaken before environmental release.

Whether the precautionary principle had been properly applied.

Whether potential impacts on biodiversity and indigenous varieties had been adequately considered.

Judicial outcome:

The two judges delivered separate opinions.

Justice B.V. Nagarathna emphasised the need for comprehensive environmental risk assessment and raised concerns about the adequacy of the approval process.

Justice Sanjay Karol took a different approach, recognising the importance of scientific research and the development of scientific temper while considering the precautionary principle.

The disagreement resulted in a split verdict and reference for consideration by a larger Bench.

Relevance to biological experiment classification:

This decision is particularly important because it demonstrates that biological risk assessment must consider:

Potential effects on biodiversity.

Uncertainty surrounding long-term environmental consequences.

Scientific transparency.

Independent regulatory scrutiny.

The adequacy of evidence supporting approval.

It also illustrates that scientific development and environmental precaution must be considered together.

SciGov+1

Case 6. M.C. Mehta v. Union of India (Oleum Gas Leak Case) (1987)

Supreme Court of India

Citation: (1987) 1 SCC 395.

Facts:

The litigation arose following the leakage of oleum gas from a chemical industrial unit in Delhi, resulting in exposure and harm.

Legal issue:

Whether enterprises engaged in hazardous activities should be subject to a special standard of liability.

Judgment:

The Supreme Court developed the doctrine of absolute liability for enterprises engaged in hazardous or inherently dangerous activities.

Relevance to biological experiments:

Although this was not a biotechnology case, its reasoning is relevant to laboratories and institutions conducting hazardous biological research.

Where a biological research activity creates serious risks, an institution cannot rely merely on the argument that reasonable care was exercised to escape the applicable liability.

The decision strengthens the principle that hazardous research activities must be accompanied by appropriate preventive safeguards and accountability.

9. Legal Principles Emerging from the Case Laws

The above decisions establish several principles relevant to biological experiment classification.

10. Regulatory Authorities and Their Responsibilities

Biological risk classification involves several institutional and regulatory actors.

In India:

Ministry of Environment, Forest and Climate Change (MoEFCC): Environmental policy and statutory oversight.

Genetic Engineering Appraisal Committee (GEAC): Appraisal of specified activities involving genetically engineered organisms.

Institutional Biosafety Committees (IBSCs): Institutional scrutiny and monitoring of relevant research.

Review Committee on Genetic Manipulation (RCGM): Scientific monitoring and review within its regulatory mandate.

State Biotechnology Coordination Committees (SBCCs): State-level coordination and monitoring.

District Level Committees (DLCs): Local-level monitoring and enforcement under the applicable framework.

Their responsibilities include reviewing applications, evaluating risks, requiring safeguards, inspecting facilities and responding to non-compliance.

11. Legal Consequences of Incorrect Risk Classification

Incorrect classification can create serious legal consequences.

A. Administrative consequences

Suspension of experimental activities.

Withdrawal or modification of approvals.

Regulatory investigations.

Restrictions on laboratory operations.

Additional compliance requirements.

B. Civil liability

An institution may face claims where negligence, breach of statutory duties or other legally recognised grounds establish responsibility for injury or environmental damage.

C. Criminal liability

Where statutory offences are established, responsible persons or organisations may face prosecution under the applicable legislation.

D. Environmental liability

Accidental biological release or contamination may result in environmental restoration obligations, compensation claims and enforcement proceedings.

E. Institutional accountability

Universities, research centres and private biotechnology companies may face internal disciplinary action, loss of research privileges and regulatory restrictions.

12. Major Legal Challenges in Risk Classification

Several unresolved issues continue to challenge biological research regulation.

1. Scientific uncertainty: New biological technologies may produce consequences that cannot be fully predicted.

2. Emerging biotechnology: Synthetic biology, genome editing and advanced cell technologies create regulatory questions that older classification systems may not adequately address.

3. Cross-border research: A biological experiment approved in one country may be subject to different regulatory classifications in another.

4. Long-term consequences: Some biological changes may have effects that become apparent only after considerable time.

5. Regulatory inconsistency: Different institutions may classify similar experimental activities differently.

6. Commercial pressure: Financial and commercial interests may influence decisions concerning research approval and safety assessment.

7. Accountability gaps: Responsibility may be divided between researchers, universities, sponsors, contractors and regulatory institutions.

13. Recommendations for Legal and Regulatory Reform

A stronger regulatory system for biological experiment classification should incorporate the following reforms:

Standardised risk-assessment criteria: Establish consistent scientific and legal criteria for classifying biological experiments.

Independent scientific review: Ensure that high-risk research receives independent evaluation.

Periodic reclassification: Update risk categories when scientific knowledge or experimental conditions change.

Mandatory documentation: Require researchers to maintain records of risk assessments and regulatory approvals.

Transparent decision-making: Publish appropriate summaries of regulatory assessments and approval decisions.

Long-term monitoring: Introduce monitoring requirements for experiments with potentially lasting environmental consequences.

Clear liability rules: Establish responsibility for researchers, institutions, sponsors and biotechnology companies.

International coordination: Harmonise relevant biosafety standards to facilitate responsible cross-border research.

14. Conclusion

Risk classification of biological experiments is an essential mechanism for balancing scientific innovation with human safety, environmental protection and legal accountability.

The Indian legal framework, particularly the Environment (Protection) Act, 1986 and the 1989 Rules, provides an important foundation for controlling hazardous microorganisms and genetically engineered organisms.

Judicial decisions such as Vellore Citizens' Welfare Forum, A.P. Pollution Control Board v. Nayudu, Aruna Rodrigues v. Union of India and M.C. Mehta v. Union of India provide important principles for assessing potentially hazardous scientific activities.

The most significant legal development is the recognition that scientific uncertainty does not automatically justify regulatory approval. Instead, regulatory authorities must consider the seriousness of potential harm, the quality of scientific evidence and the effectiveness of preventive safeguards.

Ultimately, an effective biological risk classification system must be scientifically informed, legally enforceable, transparent, proportionate and adaptable to emerging technologies.

15. Important Legal References and Research Materials

Useful authoritative reading:

WHO Laboratory Biosafety Manual, Fourth Edition

WHO Risk Assessment Guidance

India's 1989 Genetically Engineered Organisms Rules

Australian Gene Technology Act 2000

Aruna Rodrigues – Supreme Court proceedings

Aruna Rodrigues – 2024 Supreme Court judgment

Legal research note: The environmental judgments discussed above establish principles applicable to biological risk regulation; they should not all be understood as direct judicial decisions on laboratory risk classification. The specific statutory requirements depend on the biological material, experimental activity and applicable jurisdiction.